Patients seeking psilocybin-therapy for end-of-life distress will soon be in good hands. In response to the explosion of interest from the mental health community for psychedelic-assisted therapy programs, TheraPsil–a non-profit, patient-rights advocacy group–is in the process of launching a program to provide training for participants to become intimately familiar with the modality, as well as access to a support network of other healthcare professionals.
Share this post
